Teva Pharmaceutical Industries Limited company logo
Teva Pharmaceutical Industries Limited logo

TEVA Cash From Financing

Annual CFF

-$1.74B$177.80M+9.29%

Summary

Current Value
As of today, TEVA annual cash from financing is -$1.74B, up +9.29% on
Historical Performance
TEVA annual cash from financing is up +20.11% over the past 3 years, and up +9.91% over the past 5 years
All-Time High Comparison
TEVA annual cash from financing is currently -106.86% below its historical high of $25.30B set on
3-Year Low Comparison
TEVA annual cash from financing is +9.29% above its 3-year low of -$1.91B reached on
Sector Comparison
TEVA annual cash from financing is higher than 2.54% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

TEVA Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing-$1.74B+9.3%+20.1%+9.9%+23.2%
Quarterly Cash From Financing-$455.07M-100.0%-3.4%+57.0%-114.2%
TTM Cash From Financing-$2.84B-74.5%-122.6%-42.0%-417.7%
Price$32.40+50.0%+208.0%+192.7%-40.0%
Annual Cash From Operations$2.55B-10.4%+4.3%+14.1%-24.3%
Annual Cash From Investing-$565.67M-11.1%-352.5%-328.5%+38.1%
Annual Dividends Paid$0.000.0%0.0%-100.0%-100.0%
Annual Total Debt$18.17B-10.3%-22.9%-33.9%+223.3%
Shares Outstanding1.15B+1.2%+3.3%+4.6%

Cash From Financing Highs

TEVA Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y-$1.48BN/A-17.1%
5Y-$1.48B-17.1%
All$25.30B-106.9%

Cash From Financing Lows

TEVA Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y-$1.91B+9.3%
5Y-$2.17B+20.1%
All-$5.79B+70.1%

Cash From Financing History

YearValueChange
-$1.74B+9.3%
-$1.91B-29.2%
-$1.48B+31.8%
-$2.17B-15.2%
-$1.89B+2.1%
-$1.93B+42.3%
YearValueChange
-$3.34B+42.4%
-$5.79B-122.9%
$25.30B+426.6%
$4.81B+302.3%
-$2.38B-

FAQ

  • What is the current annual cash from financing of TEVA?

    As of today, TEVA annual cash from financing is -$1.74B

  • What is 1-year change in TEVA annual cash from financing?

    TEVA annual cash from financing is up +9.29% year-over-year

  • What is 3-year change in TEVA annual cash from financing?

    TEVA annual cash from financing is up +20.11% over the past 3 years

  • How far is TEVA annual cash from financing from its all-time high?

    TEVA annual cash from financing is currently -106.86% below its historical high of $25.30B set on December 31, 2016

  • How does TEVA annual cash from financing rank versus sector peers?

    TEVA annual cash from financing is higher than 2.54% of companies in Healthcare sector

  • When is TEVA next annual earnings release?

    The next annual earnings release for TEVA is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. TEVA Official Website www.tevapharm.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/818686/000119312525266895/0001193125-25-266895-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/818686/000119312525020826/0001193125-25-020826-index.htm
  4. TEVA Profile on Yahoo Finance finance.yahoo.com/quote/TEVA
  5. TEVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/teva